Cargando…

804. Impact of Azithromycin Prophylaxis in Lung Transplant Recipients on the Risk of Nontuberculous Mycobacterial Infections

BACKGROUND: Azithromycin has been shown to improve FEV1 in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS). The impact of azithromycin use on the incidence of infections due to Mycobacterium avium complex (MAC) and M. abscessus in LTR is currently unknown. METHODS: We c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Workman, Adrienne, Kaza, Vaidehi, Bennett, Scott, Chong, Pearlie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254516/ http://dx.doi.org/10.1093/ofid/ofy210.811

Ejemplares similares

2571. Norovirus Infection and Gut Microbiota in Transplant Recipients
por: Chong, Pearlie P, et al.
Publicado: (2019)

1389. Nontuberculous Mycobacterial Infections of the Upper Extremity
por: Polveroni, Thomas M, et al.
Publicado: (2021)

Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients
por: Okamoto, Koh, et al.
Publicado: (2020)

Extrapulmonary Nontuberculous Mycobacterial Infections in Southern Arizona
por: Florita, Catalin, et al.
Publicado: (2017)

1639. Lung Transplant Outcomes in Patients with Chronic Respiratory Disease and Pre-Operative Nontuberculous Mycobacterial Disease
por: McGuffin, Sarah, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the USA
por: Marras, Theodore, et al.
Publicado: (2017)

122. All-Cause Mortality Increased With Nontuberculous Mycobacterial Lung Disease in US Medicare
por: Marras, Theodore, et al.
Publicado: (2018)

780. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare, 2008–2015
por: Winthrop, Kevin L, et al.
Publicado: (2018)

2695. Lung Transplant Recipients With High Risk Cytomegalovirus Mismatch Donors Managed Using A Multimodality Regimen: A Five-Year Study
por: Banga, Amit, et al.
Publicado: (2023)

Epidemiology of Nontuberculous Mycobacterial Lung Disease among Cystic Fibrosis Patients Residing in Hawaii, USA
por: Adjemian, Jennifer, et al.
Publicado: (2017)

1884. Metagenomic Sequencing of the Lung Microbiota Facilitates Diagnosis and Prognosis of Nontuberculous Mycobacterial Pulmonary Disease
por: Chen, Yu, et al.
Publicado: (2023)

Nontuberculous mycobacterial osteomyelitis
por: Bi, Sheng, et al.
Publicado: (2015)

1386. Reduction in Expected Survival Associated with Nontuberculous Mycobacterial Pulmonary Infection
por: Mourad, Ahmad, et al.
Publicado: (2019)

Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2016)

Recent advances in nontuberculous mycobacterial lung infections
por: Horne, David, et al.
Publicado: (2019)

The lung microbiota in nontuberculous mycobacterial pulmonary disease
por: Kim, Bo-Guen, et al.
Publicado: (2023)

The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
por: Wang, Ping-Huai, et al.
Publicado: (2022)

Nontuberculous mycobacterial infection after lung transplantation: a report of four cases
por: Ose, Naoko, et al.
Publicado: (2019)

1136. Universal Prophylaxis for Prevention of Invasive Aspergillus in Lung Transplant Recipients
por: Guenette, Alexis, et al.
Publicado: (2018)

1706 Characteristics of Nontuberculous Mycobacterial Infections in Thai Population
por: Nanthtanti, Nithita, et al.
Publicado: (2014)

461 Clostridium difficile Infection and Mortality in Lung Transplant Recipients: A Single-Center Retrospective Cohort Study
por: Chong, Pearlie P., et al.
Publicado: (2014)

Recurrent Nontuberculous Mycobacterial Tenosynovitis
por: Kwan, Melissa, et al.
Publicado: (2021)

2138. Impact of De-escalation of Antibiotic Surgical Prophylaxis in Lung Transplant Recipients
por: Gandotra, Sumit, et al.
Publicado: (2018)

Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
por: Jeon, Doosoo
Publicado: (2019)

Comment on “nontuberculous mycobacterial infection after lung transplantation: a report of four cases”
por: Keikha, Masoud, et al.
Publicado: (2019)

Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease
por: Cowman, Steven A., et al.
Publicado: (2018)

782. Risk Factors, Clinical Characteristic, and Treatment Outcomes for Nontuberculous Mycobacterial Disease in Mexico
por: Luis, Bruno Ali Lopez, et al.
Publicado: (2018)

1359. Clinical Experience and Challenges Utilizing Clofazimine in the Treatment of Nontuberculous Mycobacterial Pulmonary Infections
por: Mercurio, Amanda, et al.
Publicado: (2019)

1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018)

Rate of All-cause Hospitalization at Year 2 Between Treatment Groups Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the USA
por: Marras, Theodore, et al.
Publicado: (2017)

1428. Clinical Characteristics and Management of Nontuberculous Mycobacterial Infections in the Finger Lakes Region of New York
por: Croix, Michael, et al.
Publicado: (2022)

Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease
por: Ellis, Huw C., et al.
Publicado: (2023)

Diagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease in Korea
por: Kwon, Yong Soo, et al.
Publicado: (2014)

Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives
por: Ryu, Yon Ju, et al.
Publicado: (2016)

Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA
por: Adjemian, Jennifer, et al.
Publicado: (2017)

Management of pulmonary nontuberculous mycobacterial disease
por: Horan, Kathleen L, et al.
Publicado: (2009)

Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases
por: Wi, Yu Mi
Publicado: (2019)

1571. Cost-Effectiveness Analysis of Duration of Valganciclovir Prophylaxis Among CMV Serology Mismatched (Donor+/Recipient−) Lung Transplant Recipients
por: Tomko, Heather, et al.
Publicado: (2018)

1082. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial Infections: A Multicenter Evaluation
por: Morrisette, Taylor, et al.
Publicado: (2021)

1443. Nontuberculous Mycobacterial Cervicofacial Lymphadenitis Therapy: Experience from a Tertiary Care Pediatric Center
por: Vo, Anh N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c3i8080av3lpguq8gjsjr8q2p9